Branched DNA (bDNA) Technology for Direct Quantification of Nucleic Acids: Research and Clinical Applications
provides direct quantification of nucleic acid molecules at physiological levels. Since bDNA assays do not require highly purified nucleic acid preparations, inhibitors of enzyme-dependent amplification techniques are of no concern.
allows a wide diversity of specimen types to be used.
can be used with reference standards to ensure accuracy for applications requiring absolute quantification, or without standards for applications requiring only assessment of relative changes in nucleic acid concentrations.
exhibits a high level of sensitivity (moderately expressed genes can be detected using as few as 50–100 cells). The level of sensitivity can be modulated by altering the number of target-specific extenders to accommodate specific applications.
is thoroughly tested for within-lot and between-lot precision to ensure reproducibility (2.2- to 3-fold changes can be discerned as statistically significant).
KeywordsToxicity Hepatitis Lymphoma Codon Interferon
Unable to display preview. Download preview PDF.
- Bartlett JD, Luethy JD, Carlson SG, Sollott SJ, and Holbrook NJ (1992): Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)- related gene, gaddl53. Ca2+ increases transcriptional activity and mRNA stability. J Biol Chem 267:20465–70.PubMedGoogle Scholar
- Cao WW, Landay AL, Shen L-P, Siegel J, DePaz N, and Kolberg J: Quantitative analysis of cytokine expression in peripheral blood mononuclear cells from HIV-infected individuals (in preparation).Google Scholar
- Chernoff DN, Hoo BS, Shen L-P, Kelso RJ, Kolberg JA, Drew WL, Miner RC, Lalezari JP, and Urdea MS: Quantification of CMV DNA in peripheral blood leukocytes using a branched DNA (bDNA) signal amplification assay (submitted).Google Scholar
- Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, and Albrecht J (1994): Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337–41.PubMedCrossRefGoogle Scholar
- Eastman PS, Urdea M, Besemer D, Stempien M, and Kolberg J (1995): Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations. J Acquir Immune Defic Syndr Hum Retrovirol 9:264–73.PubMedGoogle Scholar
- Flood J, Drew WL, Miner R, Jekic-McMullen D, Shen L-P, Kolberg J, Garvey J, Follansbee S, and Poscher M: Detection of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid using branched DNA signal amplification and CMV antigen assays (submitted).Google Scholar
- Hosotsubo H et al. (1994): Quantitation of serum HBV DNA by branched DNA probe assay with chemiluminescence detection. Med Pharm 31:743–51.Google Scholar
- Kapke GF, Watson G, Sheffler S, Hunt D, and Frederick C: Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J Virol Hepatitis (in press).Google Scholar
- Lalezari JP, Drew WL, Glutzer E, James C, Miner D, Flaherty J, Fisher PE, Cundy K, Hannigan J, Martin JC, and Jaffe HS (1995): (S)-l-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis 171:788–96.PubMedCrossRefGoogle Scholar
- Lin HJ, Myers LE, Yen LB, Hollinger FB, Henrard D, Hooper CJ, Kokka R, Kwok S, Rasheed S, Vahey M, Winters MA, McQuay LJ, Nara PL, Reichelderfer P, Coombs RW, and Jackson JB (1994): Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 170:553–62.PubMedCrossRefGoogle Scholar
- Shen L-P, Sheridan P, Cao W, Dailey PJ, Urdea MS, and Kolberg J: Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology (in preparation).Google Scholar
- Terrault N, Wilber J, and Feinman SV (1994): Response to interferon therapy predicted by changes in serum HCV-RNA titer early in treatment. In Program and Abstracts of the Digestive Diseases Meeting, New Orleans, LA.Google Scholar
- Todd J, Pachl C, White R, Yeghiazarian T, Johnson P, Taylor B, Holodniy M, Kern D, Hamren S, Chernoff D, and Urdea M (1995): Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J Acquir Immune Defic Syndr Hum Retrovirol 10 (supplement 2):S35-S44.PubMedGoogle Scholar
- Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, and Mizokami M (1996): Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. J Med Virol 48:354–9.PubMedCrossRefGoogle Scholar
- Wang J, Shen L-P, Najafi H, Kolberg JA, Matschinsky FM, Urdea M, and German M (1997): Regulation of insulin preRNA splicing by glucose. Proc Natl Acad Sci USA (in press).Google Scholar
- Watanabe Y, Hino K et al. (1993): Detection of HBV DNA by bDNA probe assay and evaluation of its clinical utility. Med Pharm 30:1217–26.Google Scholar